cvs glp-1 program Impact of formulary change on prescribing Thinking about GLP‑1s—or just curious?

By employing a robust study design that included two control groups (DM control and non-DM control), we were able to comprehensively evaluate the increased cancer risk in patients with T2DM compared to individuals without diabetes

However, safety concerns have persisted for years regarding the pancreatic effects of GLP-1 RAs

Glucagon-like peptide-1 agonists and clinical outcomes in Polycythemia Vera: A large-scale propensity-matched cohort study

Growth hormone secretagogues like CJC-1295 and ipamorelin may counteract muscle loss during calorie restriction, though adding complexity increases cost and risk

Because like I said [00:54:00] before, being smaller at any cost

T.OroD.OvergaardA.SalinasC